&nbsp;

Drugs Used:

bortezomib (PDRP prior authorization),

lenalidomide,

dexamethasone

... Show more tags

Quick Link(s):

Regimen Monograph

Regimen

BORTDEXALENA(LD)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - In Combination with Lenalidomide and Dexamethasone for Previously Untreated Multiple Myeloma Pre-SCT

ODB Limited Use

lenalidomide - Induction therapy for transplant eligible, newly diagnosed multiple myeloma, according to clinical criteria

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Drug

anastrozole

Other Name(s): Arimidex®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Dec 1969

Regimen

CHP+BREN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade,

Lymphoma - T-cell

Intent: Curative, Palliative

Funding:

ODB - General Benefit

prednisone

New Drug Funding Program

Brentuximab Vedotin - In Combination with Chemotherapy for Previously Untreated Peripheral T-cell Lymphoma (PTCL)

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2026

Regimen

CEP+BREN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade,

Lymphoma - T-cell

Intent: Curative, Palliative

Funding:

ODB - General Benefit

prednisone

New Drug Funding Program

Brentuximab Vedotin - In Combination with Chemotherapy for Previously Untreated Peripheral T-cell Lymphoma (PTCL)

ODB - General Benefit

etoposide - oral capsules

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2026

Regimen

CAPE(RT)

Cancer Type:

Gastrointestinal,

Rectal

Intent: Neoadjuvant

Funding:

ODB - General Benefit

capecitabine

Drugs Used:

capecitabine

... Show more tags

Quick Link(s):

Regimen Monograph

Drug

relugolix

Other Name(s): Orgovyx®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Dec 1969

Drug

goserelin

Other Name(s): Zoladex® , Zoladex® LA

Quick Link(s):

Drug Monograph, Patient Info Sheet

Updated

Mar 2026

Regimen

GOSE

Cancer Type:

Breast

Intent: Adjuvant, Palliative

Funding:

ODB - General Benefit

goserelin

Drugs Used:

goserelin

... Show more tags

Quick Link(s):

Regimen Monograph

Updated

Mar 2026

Regimen

BORTDEXASELI

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - In Combination with Selinexor and Dexamethasone for Previously Treated Multiple Myeloma

ODB - General Benefit

dexamethasone

Exceptional Access Program

selinexor - In combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma

Drugs Used: